Literature DB >> 11096452

The interferon-inducible Staf50 gene is downregulated during T cell costimulation by CD2 and CD28.

C Gongora1, C Tissot, C Cerdan, N Mechti.   

Abstract

It is well established that interferons (IFN) exert potent regulatory effects on the immune system. We have recently isolated a new IFN-induced human cDNA coding for a member of the Ring finger B-box/B30.2 subfamily that localizes to the chromosome band 11p15. We have named it Staf50. We show in this report that Staf50 is expressed in resting T cells in the absence of exogenous IFN treatment and is strongly repressed during T cell activation by anti-CD28 and anti-CD2 monoclonal antibodies (mAb) at both messenger and protein levels. In addition, we show that several members of the Ring finger B-box/B30.2 subfamily, including the 52-kDa SSA/Ro autoantigen, localize to the same chromosome band, 11p15, and are upregulated by IFN. These data led us to define a family of IFN-induced genes clustered on chromosome 11p15 that may be involved in T cell regulatory processes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11096452     DOI: 10.1089/10799900050198390

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  14 in total

1.  Induction of TRIM22 by IFN-γ Involves JAK and PC-PLC/PKC, but Not MAPKs and pI3K/Akt/mTOR Pathways.

Authors:  Bo Gao; Wei Xu; Yaxin Wang; Linmao Zhong; Sidong Xiong
Journal:  J Interferon Cytokine Res       Date:  2013-05-09       Impact factor: 2.607

2.  TRIM22 inhibits HIV-1 transcription independently of its E3 ubiquitin ligase activity, Tat, and NF-kappaB-responsive long terminal repeat elements.

Authors:  Anna Kajaste-Rudnitski; Sara S Marelli; Cinzia Pultrone; Thomas Pertel; Pradeep D Uchil; Nadir Mechti; Walther Mothes; Guido Poli; Jeremy Luban; Elisa Vicenzi
Journal:  J Virol       Date:  2011-02-23       Impact factor: 5.103

3.  Estrogen induced breast cancer is the result in the disruption of the asymmetric cell division of the stem cell.

Authors:  Jose Russo; Kara Snider; Julia S Pereira; Irma H Russo
Journal:  Horm Mol Biol Clin Investig       Date:  2010-01-01

4.  TRIM proteins and cancer.

Authors:  Shigetsugu Hatakeyama
Journal:  Nat Rev Cancer       Date:  2011-10-07       Impact factor: 60.716

5.  TRIM22 inhibits osteosarcoma progression through destabilizing NRF2 and thus activation of ROS/AMPK/mTOR/autophagy signaling.

Authors:  Wei Liu; Yuechao Zhao; Guangfu Wang; Shuang Feng; Xuhui Ge; Wu Ye; Zhuanghui Wang; Yufeng Zhu; Weihua Cai; Jianling Bai; Xuhui Zhou
Journal:  Redox Biol       Date:  2022-05-18       Impact factor: 10.787

6.  Hsp70 interacts with the retroviral restriction factor TRIM5alpha and assists the folding of TRIM5alpha.

Authors:  Chae Young Hwang; Jens Holl; Devi Rajan; Younglang Lee; Susan Kim; Moonkyoung Um; Ki-Sun Kwon; Byeongwoon Song
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

7.  Different subcellular localisations of TRIM22 suggest species-specific function.

Authors:  Anna-Maria Herr; Ralf Dressel; Lutz Walter
Journal:  Immunogenetics       Date:  2009-02-11       Impact factor: 2.846

8.  TRIM22: A Diverse and Dynamic Antiviral Protein.

Authors:  Clayton J Hattlmann; Jenna N Kelly; Stephen D Barr
Journal:  Mol Biol Int       Date:  2012-05-08

9.  Delayed polarization of mononuclear phagocyte transcriptional program by type I interferon isoforms.

Authors:  David F Stroncek; Christopher Basil; Dirk Nagorsen; Sara Deola; Eleonora Aricó; Kina Smith; Ena Wang; Francesco M Marincola; Monica C Panelli
Journal:  J Transl Med       Date:  2005-06-13       Impact factor: 5.531

10.  The interferon response inhibits HIV particle production by induction of TRIM22.

Authors:  Stephen D Barr; James R Smiley; Frederic D Bushman
Journal:  PLoS Pathog       Date:  2008-02-29       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.